Dark

EOLS
Evolus, Inc. Common Stock
stock NASDAQ

At Close

Aug 7, 2026 3:59:57 PM EDT

7.58USD+2.294%(+0.17)1,630,865

0.00Bid 0.00Ask 0.00Spread

Pre-market

Aug 6, 2026 9:28:30 AM EDT

6.92USD-6.613%(-0.49)0

After-hours

Aug 7, 2026 4:00:30 PM EDT

7.44USD-1.847%(-0.14)193,074

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

500.66M

CEO

David Moatazedi

Headquarters

Newport Beach, California, USA

Industry

Drug Manufacturers-Specialty & Generic

XLV

EOLS Stats

Avg. Vol. 10 Day

1,006,404

Avg. Vol. 30 Day

873,959

Employees

Market Cap

500,662,335

Shares Out.

66,050,440

On/Off Exchange

64%/36%

6 Month Beta

1.19

1 Year Beta

1.15

2 Year Beta

1.21

3 Year Beta

1.12

52 Week Low

3.86

52 Week High

7.95

SMA50

6.49

SMA200

5.89

1 Week

+29.80%

1 Month

+11.64%

3 Month

+19.18%

6 Month

+78.77%

1 Year

+28.48%

2 Year

-41.83%

5 Year

-34.20%

Profile

evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.

EOLS Stock Summary

Evolus, Inc. Common Stock (NASDAQ:EOLS) stock price today is $7.58, and today's volume is 1,630,865. EOLS is up 2.294% today. The 30 day average volume is 873,959. EOLS market cap is 500.66M with 66,050,440 shares outstanding.

.dark-mode .v9Cqrx{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .v9Cqrx{ color: #333333; background-color: white; border: 2px solid #333333; }EOLSEvolus, Inc. Common Stockstock NASDAQ

EOLS Stock Summary

EOLS
Evolus, Inc. Common Stock
stock NASDAQ